DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Folegatti PM, Ewer KJ, Aley PK. et al; Oxford COVID Vaccine Trial Group.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet 2020;
396 (10249): 467-478
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.